Point State Capital LP Pacira Bio Sciences, Inc. Transaction History

Point State Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $10.6 Million - $13.3 Million	-255,700 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $44.9 Million - $71.1 Million	-1,366,984 Reduced 84.24%	255,700 $12.6 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $11.4 Million - $16.5 Million	-415,469 Reduced 20.38%	1,622,684 $52 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $25.4 Million - $39.3 Million	847,146 Added 71.13%	2,038,153 $63.5 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $1.69 Million - $2.49 Million	53,107 Added 4.67%	1,191,007 $54.4 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $20.2 Million - $22.4 Million	566,400 Added 99.11%	1,137,900 $42.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	571,500	571,500 $27.3 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.